Recent Updates
Recently added Catalysts
FULC Positive Sentiment Score: 60/100

Fulcrum Therapeutics to Host Second Quarter 2024 Financial Results Conference Call and Webcast on Wednesday, July 31, 2024, at 8:00 a.m. ET

Wednesday, July 24, 2024 1 min read
Key Takeaway: Fulcrum Therapeutics, a biopharmaceutical company, has announced its second quarter 2024 financial results will be released on July 31, 2024. A conference call and webcast will take place at 8:00 a.m. ET on the same day to discuss these results and recent corporate developments. Interested individuals are encouraged to register for the call, and an audio webcast will be made available through the company's website post-event.

Market Sentiment Analysis

POSITIVE FACTORS

  • Fulcrum Therapeutics is providing timely information about its financial results.
  • The conference call allows investors to engage directly with the management.
  • The company's focus is on developing solutions for rare diseases, which is beneficial for patients.

Full Press Release Details

CAMBRIDGE, Mass., July 24, 2024 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc.® (the “Company”) (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of patients with genetically defined rare diseases, today announced that its second quarter 2024 financial results will be released on Wednesday, July 31, 2024, before the U.S. financial markets open. Management will host a conference call and webcast at 8:00 a.m. ET to discuss the results and provide an update on recent corporate developments.
Individuals may register for the conference call by clicking the link here. Once registered, participants will receive dial-in details and unique PIN which will allow them to access the call. An audio webcast will be accessible through the Investor Relations section of the company’s website at www.fulcrumtx.com or by clicking here. Following the live webcast, an archived replay will also be available.
About Fulcrum Therapeutics
LifeSci Advisors, LLC
ccalabrese@lifesciadvisors.com

Frequently Asked Questions

When will Fulcrum Therapeutics release its Q2 2024 results?

Fulcrum Therapeutics will release its Q2 2024 financial results on July 31, 2024.

What time is the conference call for Q2 2024 results?

The conference call will take place at 8:00 a.m. ET on July 31, 2024.

How can I access the conference call for Fulcrum Therapeutics?

Participants can register online to receive call details and a unique PIN.

Where can I find the audio webcast of the conference call?

The audio webcast will be available on Fulcrum Therapeutics' Investor Relations page.

Will a replay of the conference call be available?

Yes, an archived replay of the webcast will be accessible after the live event.

Tags: FULC Viatris Investor Conferences Healthcare Fulcrum Therapeutics Q2 2024 results financial call biopharmaceutical company rare diseases
Last updated: Jul 24, 2024